Alessandro Boccanelli Selected Research

Canrenone

9/2017	Galectin-3 and the Mineralocorticoid Receptor Antagonist Canrenone in Mild Heart Failure.
1/2009	Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results.
9/2007	Baseline characteristics of patients recruited in the AREA IN-CHF study (Antiremodelling Effect of Aldosterone Receptors Blockade with Canrenone in Mild Chronic Heart Failure).
5/2005	[The AREA IN-CHF trial (antiremodeling effect of aldosterone receptors blockade with canrenone in mild chronic heart failure): rationale and design].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Boccanelli Research Topics

Disease

13	Heart Failure 08/2022 - 08/2002
6	Myocardial Infarction 10/2021 - 09/2003
3	Inflammation (Inflammations) 08/2021 - 09/2017
3	ST Elevation Myocardial Infarction 12/2017 - 09/2003
3	Left Ventricular Dysfunction 10/2013 - 05/2005
2	Frailty 08/2022 - 08/2022
2	Aortic Valve Stenosis (Aortic Stenosis) 08/2022 - 08/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 12/2007
2	Chronic Renal Insufficiency 01/2021 - 02/2014
2	Hypotension (Low Blood Pressure) 03/2019 - 08/2010
2	Acute Coronary Syndrome 07/2018 - 02/2014
2	Fibrosis (Cirrhosis) 09/2017 - 05/2005
2	Non-ST Elevated Myocardial Infarction 01/2014 - 09/2003
2	Stroke (Strokes) 01/2014 - 12/2007
2	Respiratory Sounds (Crackle) 10/2010 - 05/2005
2	Sudden Death 12/2007 - 05/2005
1	Cognitive Dysfunction 08/2022
1	Endocarditis 08/2022
1	Hypertension (High Blood Pressure) 08/2022
1	Ischemic Stroke 08/2022
1	Genetic Risk Score 10/2021
1	Ventricular Dysfunction 01/2021
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 05/2019
1	Atherosclerosis 01/2019
1	Serotonin Syndrome (Syndrome, Serotonin) 01/2015
1	Cardiovascular Abnormalities 01/2015
1	Drug-Related Side Effects and Adverse Reactions 01/2015
1	Renal Hypertension 01/2014
1	Diabetes Mellitus 01/2014
1	Death (Near-Death Experience) 01/2009
1	Coronary Disease (Coronary Heart Disease) 12/2007
1	Essential Hypertension 01/2007
1	Hyperlipidemias (Hyperlipidemia) 05/2006
1	Hyperplasia 10/2002
1	Pathologic Constriction (Stenosis) 10/2002
1	Bundle-Branch Block (Fascicular Block) 08/2002
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 08/2002
1	Neointima 08/2002

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 10/2021 - 08/2002
4	CanrenoneIBA 09/2017 - 05/2005
4	Mineralocorticoid Receptor AntagonistsIBA 09/2017 - 09/2007
3	AldosteroneIBA 10/2010 - 05/2005
3	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 10/2010 - 05/2005
2	pro-brain natriuretic peptide (1-76)IBA 05/2019 - 10/2013
2	CollagenIBA 01/2019 - 09/2017
1	Biological ProductsIBA 08/2022
1	AnticoagulantsIBA 08/2022
1	oxidized low density lipoproteinIBA 10/2021
1	CalciumIBA 08/2021
1	CreatinineIBA 01/2021
1	insulin-like growth factor binding protein-related protein 1IBA 01/2021
1	sacubitrilIBA 03/2019
1	Valsartan (Vals)FDA Link 03/2019
1	Natriuretic PeptidesIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	CholesterolIBA 01/2019
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 07/2018
1	Galectin 3 (LGALS3)IBA 09/2017
1	Serotonin (5 Hydroxytryptamine)IBA 01/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2014
1	DiureticsIBA 08/2010
1	Potassium Sparing DiureticsIBA 08/2010
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2010
1	Adenosine (Adenocard)FDA LinkGeneric 08/2010
1	ElectrolytesIBA 08/2010
1	Coffee FDA Link 12/2007
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2007
1	Olmesartan Medoxomil (Votum)FDA Link 01/2007
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 05/2006
1	Eplerenone (Inspra)FDA LinkGeneric 05/2005
1	Spironolactone (Aldactone)FDA LinkGeneric 05/2005
1	procollagen Type III-N-terminal peptide (PIIP)IBA 05/2005
1	Pravastatin (Pravachol)FDA LinkGeneric 08/2002

Therapy/Procedure

11	Therapeutics 08/2022 - 08/2002
3	Percutaneous Coronary Intervention 12/2017 - 01/2009
2	Transcatheter Aortic Valve Replacement 08/2022 - 08/2022
2	Stents 10/2002 - 08/2002
1	Vascular Surgical Procedures 08/2022
1	Drug Therapy (Chemotherapy) 08/2022
1	Catheter Ablation 08/2022
1	Complementary Therapies (Alternative Medicine) 08/2010
1	Secondary Prevention 01/2009
1	Thrombolytic Therapy 01/2009
1	Length of Stay 09/2003
1	Treatment Delay 09/2003
1	Cardiac Resynchronization Therapy 08/2002